Genetic Variations in the PI3K/PTEN/AKT/mTOR Pathway Are Associated With Clinical Outcomes in Esophageal Cancer Patients Treated With Chemoradiotherapy

PURPOSE: The phosphoinositide-3-kinase (PI3K), phosphatase and tensin homolog (PTEN), v-akt murine thymoma viral oncogene homolog (AKT), and mammalian target of rapamycin (mTOR) signaling pathway has been implicated in resistance to several chemotherapeutic agents. In this retrospective study, we de...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hildebrandt, Michelle A.T., Yang, Hushan, Hung, Mien-Chie, Izzo, Julie G., Huang, Maosheng, Lin, Jie, Ajani, Jaffer A., Wu, Xifeng
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Clinical Oncology 2009
Gaiak:
Original Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2738430/
https://ncbi.nlm.nih.gov/pubmed/19164214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.17.6297
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak